2026 Q2 Portfolio Activity
In 2026 Q2, venBio Partners LLC maintained a portfolio of 8 distinct positions. The most significant new addition was PARABILIS MEDICINES INC, now representing 27.75% of the total fund value. Conversely, venBio Partners LLC completely exited their position in ARTIVA BIOTHERAPEUTICS INC.
Position History
hover any row below to update
Loading…
Total Positions
8
Quarter
2026 Q2
Top Holding
PHVS (30.9%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-8 of 8
venBio Partners LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PHVS
PHARVARIS N V
|
Healthcare | 30.92% | 46.71% |
#1
Prev: #1
|
6.5 |
—
|
4,126 | 0.1% |
P
S
|
4,643,430 | $160,569,809 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
PARABILIS MEDIC...
|
|
Unknown | 27.75% | — |
#2
Prev: #—
|
9.0 |
—
|
5,266,697 | — |
NEW
|
5,266,697 | $144,149,497 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ALMS
ALUMIS INC
|
Healthcare | 24.53% | 35.56% |
#3
1
Prev: #2
|
6.0 |
—
|
no change | no change |
P
S
|
4,528,408 | $127,429,401 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACHV
ACHIEVE LIFE SC...
|
Healthcare | 7.44% | — |
#4
Prev: #—
|
7.0 |
—
|
5,914,720 | — |
NEW
|
5,914,720 | $38,623,122 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALXO
ALX ONCOLOGY HL...
|
Healthcare | 5.14% | 9.21% |
#5
2
Prev: #3
|
3.6 |
—
|
no change | no change |
P
S
|
12,884,638 | $26,671,201 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 3.31% | 4.88% |
#6
2
Prev: #4
|
1.8 |
—
|
-17,000 | -3.5% |
P
S
|
472,194 | $17,192,584 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LYEL
LYELL IMMUNOPHA...
|
Healthcare | 0.91% | 2.41% |
#7
2
Prev: #5
|
1.4 |
—
|
no change | no change |
P
S
|
337,697 | $4,744,643 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARTV
ARTIVA BIOTHERA...
|
Healthcare | 0.00% | 1.22% |
Sold All 😨
(Was: #6) |
0.0 |
—
|
-531,337 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-8 of 8 holdings